When diet and exercise are not enough, proper use of medications can help you lose weight
2025 July 8;26345161251353437
About 60-70% cluster around trial averages of 18-23% reduction
Administration Challenges: Compounded GLP-1 agonists are typically dispensed in multi-dose vials, requiring more skill and training for proper administration compared to the pen devices used for commercial products

Key differences between leptin and semaglutide include: Origin Leptin is produced by adipose tissue as a long-term energy status signal, whilst GLP-1 (mimicked by semaglutide) is secreted by intestinal cells in response to nutrient intake Receptor targets Leptin binds to leptin receptors (ObR), primarily in the hypothalamus, whereas semaglutide activates GLP-1 receptors distributed throughout multiple organ systems Temporal signalling Leptin provides chronic, tonic signals about energy stores, whilst GLP-1 delivers acute, meal-related satiety signals Clinical efficacy in obesity Leptin replacement has limited effectiveness in common obesity due to leptin resistance, whereas GLP-1 receptor agonists demonstrate robust weight loss effects regardless of baseline leptin status Despite these differences, functional similarities exist in their ultimate effects on appetite regulation
It is considered a first-line treatment